Co-Authors
This is a "connection" page, showing publications co-authored by Alessandro Armuzzi and Franco Scaldaferri.
Connection Strength
2.070
-
The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications. Inflamm Bowel Dis. 2020 08 20; 26(9):1306-1314.
Score: 0.898
-
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020 08; 8(7):775-781.
Score: 0.883
-
Letter: SARS-CoV-2 infection in two IBD patients treated with dual targeted therapy. Aliment Pharmacol Ther. 2021 03; 53(6):764-765.
Score: 0.233
-
The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center. Endosc Int Open. 2020 Jul; 8(7):E980-E984.
Score: 0.056